>

Cory berkland - Berkland C, Kim K, Pack DW. PLG microsphere size controls drug release rate through several competing factors

INTRODUCTION. Multiple sclerosis (MS) is a neurodeg

Singkome Tima, 1 Siriporn Okonogi, 2 Chadarat Ampasavate, 2 Chad Pickens, 3 Cory Berkland, 3, * and Songyot Anuchapreeda 4, * Singkome Tima 1 Nanoscience and Nanotechnology Program, Graduate School, Chiang Mai University, Chiang Mai 50200, ThailandCory Berkland, PhD Chief Executive Officer. Dr. Berkland serves as the Chairman of the Board, President, Chief Executive Officer (CEO), and Co-Founder of Bond Biosciences. …Richard Dolder, Dunwoody, Georgia; University of Georgia; "Synthesis and Characterization of Insulin-Specific 4-Arm PEG Tetramers of p79 and 2.5HIP for the Treatment of Type 1 Diabetes," Cory Berkland and Stephanie Johnson, pharmaceutical chemistryC. Berkland, K. Kim, and D.W. Pack (2004) Controlling double-walled microcapsule shell thickness offers modulated piroxicam release Journal of Biomedical Materials Research 70A(4):576-584 C. Berkland, K. Kim, and D.W. Pack (2004) Uniform double-walled polymer microspheres of controllable shell thickness Journal of Controlled Release, 96(1):101-111Cory Berkland [email protected] Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047. Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas 66047. Department of Chemical and Petroleum Engineering, University of Kansas, Lawrence, Kansas 66047Search for more papers by this authorCory Berkland’s lab studies pharmaceuticals and biomaterials with a particular emphasis on molecular design, drug formulation, and transport in the human body. Professor …Biography: Cory Berkland holds the Solon E. Summerfield Distinguished Professorship in the Department of Pharmaceutical Chemistry and in the Department of Chemical Engineering at The University of Kansas.Intratumoral cancer chemotherapy with a carrier-based immunogenic cell death eliciting platinum (IV) agent Chad Groer1, Ti Zhang1, Ruolin Lu2, Shuang Cai1, Derek Mull1, Aric Huang2, Melanie Forrest1, Cory Berkland2,3, Daniel Aires1,4, Marcus Laird Forrest1,2,* 1HylaPharm LLC, Lawrence, Kansas 2Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, Kansas16‏/05‏/2014 ... The principal investigator from the University of Kansas for the project is Cory Berkland, KU professor of chemical and petroleum engineering ...Singkome Tima, 1 Siriporn Okonogi, 2 Chadarat Ampasavate, 2 Chad Pickens, 3 Cory Berkland, 3, * and Songyot Anuchapreeda 4, * Singkome Tima 1 Nanoscience and Nanotechnology Program, Graduate School, Chiang Mai University, Chiang Mai 50200, ThailandNanoparticles, Nanocapsules And Nanogels. Acid-labile poly (N-vinyl formamide) ("PNVF") nanocapsules were synthesized by free radical polymerization of N-vinyl formamide with optional active ingredients on the surface of silica nanoparticles. Polymerization in the presence of a novel cross-linker that contains an acid-labile ketal ...Cory Berkland, PhD, is the Solon E Summerfield Distinguished Professor at the University of Kansas, US. He is a co-founder and was Chief Scientific Officer of Orbis Biosciences (now Adare Pharmaceuticals) amongst other companies including Savara Pharmaceuticals, Bond Biosciences and Orion BioScience. Professor Berkland has a PhD in Chemical and ...Cory Berkland, professor in the Department of Chemical and Petroleum Engineering and the Department of Pharmaceutical Chemistry, received the Jim Baxendale Commercialization Award. ... Berkland is the co-founder of three companies since coming to KU in 2004: Orbis Biosciences, Savara Pharmaceuticals and Orion BioScience. These companies are ...J Pharm Innov (2010) 5:70–71 DOI 10.1007/s12247-010-9084-0 EDITORIAL Cory Berkland Published online: 16 July 2010 # Springer Science+Business Media, LLC 2010 In the pharmaceutical community, nanotechnology has that particles with a diameter larger than about 10 nm may become the flavor of the day for anything with a size or …Supang Khondee, Tatyana Yakovleva, Cory Berkland. First published: 04 August 2010. https://doi.org/10.1002/app.32460. Citations: 2. Read the full text. PDF. …Cory Berkland, Chemical & Petroleum Engineering, and Pharmaceutical Chemistry; Donna Ginther, Economics; 2011. Brian Blagg, Medicinal Chemistry; Derrick Darby, Philosophy; Patricia Hawley, Psychology; Bangere Purnaprajna, Mathematics News. Four researchers named winners of University Scholarly Achievement Award for 2023(03/28/2023)Cory Berkland, PhD. WIZARD FEATURES. © 2023 DeKosky Lab.Cory Berkland, Ph.D. -Solon E. Summerfield Distinguished Professor -Chemical and Petroleum Engineering -Pharmaceutical Chemistry Contact Info [email protected] 785-864-1455 320E Multidisciplinary Research Building Personal Links Berkland Lab Biography — Associated Tracks -Bioimaging -Biomaterials & Tissue EngineeringJoe Scherrer. Executive Director, Henry Edwin Sever Institute Director, Cybersecurity Strategic Initiative Program Director, Graduate Studies in Cybersecurity Management.Loop is the open research network that increases the discoverability and impact of researchers and their work. Loop enables you to stay up-to-date with the latest discoveries and news, connect with researchers and form new collaborations.Three decades of promise have culminated in the development of gene therapies that can be applied to a broad range of human diseases. After a brief history, we provide an overview of gene therapy types and delivery methods, gene editing technologies, regulatory affairs, clinical trials, approved pro … Cory Berkland, Ph.D.-Solon E. Summerfield Distinguished Professor-Chemical and Petroleum Engineering-Pharmaceutical Chemistry; View full profile . Jonathan Brumberg, Ph.D.-Associate Professor, Speech-Language-Hearing: Sciences & Disorders-Courtesy Associate Professor, Electrical Engineering & Computer Science;Tiffany C. Suekama, Vara Aziz, Zahra Mohammadi, Cory Berkland, Stevin H. Gehrke. Synthesis and characterization of poly( N -vinyl formamide) hydrogels-A potential alternative to polyacrylamide hydrogels. Journal of Polymer Science Part A: Polymer Chemistry 2013, 51 (2) , 435-445Cory Berkland. Drugs that can be used to diffuse iron overload exist, he said, but they are absorbed throughout the body, have "nasty" side effects and are really designed for other blood ...Fourth KU professor to receive honor, one of the highest honors for an academic inventor.-Dr. Cory Berkland. Additional Information-Madison & Lila Self Graduate Fellow. Show More about Biography. 1132 Learned Hall 1530 W 15th St. Lawrence, KS 66045 Bus Route: 29 [email protected] 785-864-5258. facebook instagram twitter youtube linkedin. Admissions; Research Labs; People; Forms; Colloquium; School of Engineering; myKU; Visit KU; Apply ...Cory Berkland is a founder of, and advisor to, Orbis Biosciences, Inc. and Savara Pharmaceuticals, Inc. Additionally, both Cory Berkland and Mark Bailey are named as inventors on patents and/or patent applications relating to technologies described in this article. Part of this work was supported by NIH grants R03 AR054035 and P20 RR016443.Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...Gage Brummer, Wei Fang, Curtis Smart, Brandon Zinda, Nadia Alissa, Cory Berkland, David Miller, Nikki Cheng, CCR2 signaling in breast carcinoma cells promotes tumor growth and invasion by promoting CCL2 and suppressing CD154 effects on the angiogenic and immune microenvironments. 2020 Mar;39 (11):2275-2289. doi: 10.1038/s41388-019-1141-7.ICAM-1 mobility on the cell surface leads to a phenomenon called "clustering" during ligand binding 34. The size of ICAM-1 and the steric hindrance effect are two significant factors in receptor clustering during ligand binding to ICAM-1, dictating that the receptors stay at an optimum distance from each other 35 - 36.pH-responsive microgels are crosslinked polymer colloid particles that swell when the pH approaches the pK a of the polybase or polyacid chains. Poly(vinylamine) (PVAM) has the highest primary amine content of all amine-containing polymers.Despite much effort the preparation of colloidally stable PVAM microgels is still elusive.Search 4 grants from Maria Flynn Search 22 grants from Cory Berkland Search grants from Ronald Beyerinck Search grants from David Newbold Search grants from Orbis Biosciences, Inc.Nanoparticles, Nanocapsules And Nanogels. Acid-labile poly (N-vinyl formamide) ("PNVF") nanocapsules were synthesized by free radical polymerization of N-vinyl formamide with optional active ingredients on the surface of silica nanoparticles. Polymerization in the presence of a novel cross-linker that contains an acid-labile ketal ...1. Introduction. The uptake and distribution of nanoparticles in the lymphatic system is dependent on the size, charge, hydrophobicity, injection site, and the dose of the nanoparticles (Hawley et al., 1995; Porter, 1997; Rao et al., 2010).A number of different delivery vehicles have been employed for lymphatic imaging and drug delivery, including: liposomes, dendrimers, quantum dots ...Dr. Cory Berkland Solon E. Summerfield Distinguished Professor School of Engineering, School of Pharmacy Chemical and Petroleum Engineering, Pharmaceutical Chemistry RESEARCH INTERESTS Antigen-specific immunotherapies, sequestering cells to combat autoimmunity, autoimmunity and tolerance reintroduction, targeted drug delivery, and gene delivery.Cory Berkland, PhD. CEO, BOND BIOSCIENCES. Saint Louis, Missouri, United States. Dr. Berkland serves as the Chairman of the Board, President, Chief Executive Officer …Home. People. Cory Berkland, Ph.D. -Solon E. Summerfield Distinguished Professor. -Chemical and Petroleum Engineering. -Pharmaceutical Chemistry. Contact Info. …Todd Berkland Work Experience and Education. According to ZoomInfo records, Todd Berkland`s professional experience began in 2000. Since then Todd has changed 4 companies and 3 roles. Currently, Todd Berkland works as a Vice President, Business Development & Acquisitions at Wrench Group.Spatial and temporal control of bioactive signals in three-dimensional (3D) tissue engineering scaffolds is greatly desired. Coupled together, these attributes may mimic and maintain complex signal patterns, such as those observed during axonal regeneration or neovascularization. Seamless polymer co …Aug 5, 2020 · Cory Berkland is a professor of pharmaceutical chemistry and chemical and petroleum engineering at the University of Kansas. (Berkland Tr. 593) The Court recognized Dr. Berkland as an expert in the preparation and analysis of pharmaceutical formulations. Prof. Berkland is a co-founder of Orbis Biosciences, Savara Pharmaceuticals, Bond Biosciences and Orion BioScience. He is also a co-developer of several technologies with industrial partners. He...Introduction. Hollow particles, also referred to as capsules or vesicles, are generating interest in industry as well as scientific research. Many active ingredients have been formulated within a capsule core to protect them from the surrounding environment and/or to facilitate sustained release including; adhesives, agrochemicals, catalysts, living cells, flavor oils, pharmaceuticals ...Cory Berkland holds the Solon E. Summerfield Distinguished Professorship in the Department of Pharmaceutical Chemistry and in the Department of Chemical Engineering at The University of Kansas. He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in …Professor Berkland is currently CEO of Bond Biosciences and is an executive and chairman of the board for Kinimmune and Axioforce. The Berkland lab focuses on developing new therapeutics and biomaterials for improving human health.Introduction. Hollow particles, also referred to as capsules or vesicles, are generating interest in industry as well as scientific research. Many active ingredients have been formulated within a capsule core to protect them from the surrounding environment and/or to facilitate sustained release including; adhesives, agrochemicals, catalysts, living cells, flavor oils, pharmaceuticals ...Introduction. With approximately 174,000 cases per year, luminal breast cancers are the most common forms of breast cancer diagnosed in the US and Canada [1, 2].In contrast to Her2-overexpressing breast cancers, or triple negative breast cancers, which lack expression of estrogen receptor (ER), Progesterone receptor, and Her2, luminal breast cancers frequently express hormone and Her2 ...Cory Berkland PhD, VP Strategic Development. Kingdom Capital Portfolio Advisors. View fullsize.Na Zhang; Chuda Chittasupho; Chadarat Duangrat; Teruna J. Siahaan; Cory Berkland: 1-May-2017: Stable curcumin-loaded polymeric micellar formulation for enhancing cellular uptake and cytotoxicity to FLT3 overexpressing EoL-1 leukemic cells: Singkome Tima; Songyot Anuchapreeda; Chadarat Ampasavate; Cory Berkland; Siriporn OkonogiICAM-1 mobility on the cell surface leads to a phenomenon called "clustering" during ligand binding 34. The size of ICAM-1 and the steric hindrance effect are two significant factors in receptor clustering during ligand binding to ICAM-1, dictating that the receptors stay at an optimum distance from each other 35 - 36.Cory Berkland1,2,* 1 Department of Pharmaceutical Chemistry, University of Kansas, 2030 Becker Dr, Lawrence, KS ... *Corresponding Author; [email protected]. Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to ourJ. Daniel Griffin, Martin A. Leon, Jean R. Salash, Michael Shao, Brittany L. Hartwell, Chad J. Pickens, Joshua O. Sestak, Cory Berkland. Acute B-Cell Inhibition by Soluble Antigen Arrays Is Valency-Dependent and Predicts Immunomodulation in Splenocytes. Biomacromolecules 2019, 20 (5) , 2115-2122.May 13, 2021 · Cory Berkland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO). Abstract. Antibiotic multi-resistant pneumonia is a risk associated with long term mechanical ventilation. Vancomycin is commonly prescribed for methicillin-resistant staphylococcus aureus infections; however, current formulations of vancomycin are only given intravenously. High doses of vancomycin have been associated with severe renal toxicity.Dr. Cory Berkland Solon E. Summerfield Distinguished Professor School of Engineering, School of Pharmacy Chemical and Petroleum Engineering, Pharmaceutical Chemistry RESEARCH INTERESTSAntigen-specific immunotherapies, sequestering cells to combat autoimmunity, autoimmunity and tolerance reintroduction, targeted drug delivery, and gene delivery.RESEARCH WEBSITE CONTACT INFO [email protected] ... Jan 26, 2023 · Berkland is currently serving as the commander, 354th Fighter Wing, Pacific Air Forces, Eielson Air Force Base, Alaska. Air Force Col. Amy S. Bumgarner for appointment to the grade of brigadier ... Cory Berkland Date Defended: 11 July 2019. ii The thesis committee for Hao Lou certifies that this is the approved version of the following thesis: The Application of Machine Learning Algorithms in Understanding the Effect of Core/Shell Technique on Improving Powder CompactabilityCory Berkland Type 1 diabetes (T1D) is an autoimmune disorder which develops when insulin-producing, pancreatic beta cells are destroyed by an aberrant immune response.Cory Berkland. Pharmaceutical Chemistry University of Kansas, Lawrence, Kansas, United States. Chemical and Petroleum Engineering University of Kansas, Lawrence, Kansas, United States. Search for more papers by this author. Bradley Sullivan, Bradley Sullivan.How it works: Cory Berkland, Ph.D., professor at the University of Kansas, is a serial entrepreneur, co-founding Orbis Biosciences, Savara Pharmaceuticals and Orion Biosciences, as well as co-developing several technologies with industry partners. In late 2012, IAMI invested in novel polymer technology discovered by Dr. Berkland with the intent ... Todd Berkland Work Experience and Education. According to ZoomInfo records, Todd Berkland`s professional experience began in 2000. Since then Todd has changed 4 companies and 3 roles. Currently, Todd Berkland works as a Vice President, Business Development & Acquisitions at Wrench Group.INTRODUCTION. Multiple sclerosis (MS) is a neurodegenerative disease characterized by an inflammatory reaction against proteins in the central nervous system (CNS) leading to nervous system dysfunction and paralysis (1-3).Several FDA-approved therapies exist to treat patients with MS; however, these therapies do not cure the disease but rather are designed to slow disease progression and ...Singkome Tima, 1 Siriporn Okonogi, 2 Chadarat Ampasavate, 2 Chad Pickens, 3 Cory Berkland, 3, * and Songyot Anuchapreeda 4, * Singkome Tima 1 Nanoscience and Nanotechnology Program, Graduate School, Chiang Mai University, Chiang Mai 50200, ThailandChittasupho C, Xie S-X, Baoum A, Yakovleva T, Siahaan TJ, Berkland CJ. ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells. European Journal of Pharmaceutical Sciences. 2009; …Cory Berkland Laird Forrest Michael Hageman Jeff Krise Sue Lunte Russ Middaugh Christian Schöneich Teruna Siahaan John Stobaugh Thomas Tolbert David Volkin Michael Wang Undergraduate Research Program ...A new pH-sensitive triblock copolymer, polyethylene glycol-block-poly(2-dimethylaminoethyl methacrylate)-block-poly(2-diisopropylaminoethyl methacrylate) (PEG-PDMA-PDPA), was synthesized via atom transfer radical polymerization (ATRP).The potential of this polymer for siRNA delivery was assessed. This triblock copolymer formed nanocapsules with high siRNA encapsulation efficiency that ...Nabil A Alhakamy 1 , David T Curiel 2 , Cory J Berkland 3 Affiliations 1 Department of Pharmaceutics, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia; ... University of Kansas, Lawrence, KS 66047, USA. Electronic address: [email protected]. PMID: 33781953 DOI: 10.1016/j.drudis.2021.03.021 AbstractCory Berkland The University of Kansas Verified email at ku.edu. ... L Wang, CJ Berkland, MS Detamore. Annals of biomedical engineering 38, 2167-2182, 2010. 136: 2010: Khia Preston Director Of Operations at The UPS Store - #3263, 2473, 3354, 3723, 1152, 3443, 07543. The student ban is cruel. Expelling students in the middle of a pandemic serves no useful purpose. It does not increase their safety or the safety of U.S. nationals.A Kaviratna and P Dhar would like to acknowledge support from the Jay Award from the Higuchi Biosciences Center and the NIH (Award number: P20GM103638). N El-Gendy and C Berkland would like to acknowledge support from the Coulter Foundation and the NSF (Award number: CHE 0966614).Jun Yang, 1, 2 Sheng-Xue Xie, 3 Yiling Huang, 1, 4 Min Ling, 1 Jihong Liu, 2 Yali Ran, 1 Yanlin Wang, 4 J Brantley Thrasher, 1 Cory Berkland, 3 and Benyi Li *, 1, 4 ... C Berkland would like to acknowledge supports for the project from the Coulter Foundation, the NIH (AR054035) and the NSF (0966614).Dr. Richard Hopkins is a Thoracic Surgeon in Kansas City, MO. Find Dr. Hopkins's phone number, address, insurance information, hospital affiliations and more.Qingting Hu, 1 Megan Myers, 1 Wei Fang, 1 Min Yao, 1 Gage Brummer, 1 Justin Hawj, 1 Curtis Smart, 1 Cory Berkland, 2 and Nikki Cheng 1, 3, * Qingting Hu 1 Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, KS 66160, USABy Akihisa Nonoyama, Ph.D., Nathan Dormer, Ph.D., and Cory Berkland, Ph.D., Adare Pharma Solutions Quetiapine is an antipsychotic drug used for the treatment of schizophrenia, bipolar disorder and depression and is currently marketed as a QD tablet. An alternate presentation of the drug in the form of controlled release microspheres would ...Corresponding Author. Cory Berkland. [email protected]; Department of Pharmaceutical Chemistry, The University of Kansas, Lawrence, KS, 66047 USA. E-mail: [email protected]; [email protected] Search for more papers by this authorCory Berkland. The University of Kansas. 在 ku.edu 的电子邮件经过验证. Drug DeliveryFormulationControlled Release. 文章引用次数开放获取的出版物 ...Cory Berkland. The University of Kansas. Verified email at ku.edu. Drug Delivery Formulation Controlled Release. Articles Cited by Public access Co ... YY Lin, M Laird Forrest, CJ Berkland. Expert opinion on drug delivery 6 (11), 1175-1194, 2009. 461: 2009: Fabrication of PLG microspheres with precisely controlled and monodisperse size ...Nov 11, 2020 · Chad Groer, 1 Ti Zhang, 1 Ruolin Lu, 2 Shuang Cai, 1 Derek Mull, 1 Aric Huang, 2 Melanie Forrest, 1 Cory Berkland, 2, 3 Daniel Aires, 1, 4 and Marcus Laird Forrest 1, 2, * Chad Groer 1 HylaPharm LLC, Lawrence, Kansas Cory Berkland, PhD, Orbis Biosciences Co-Founder and Chief Scientific Officer, has demonstrated Orbis's technology capabilities for over 15 years. Cory has a ...Staymates2, and Cory Berkland1,5,* 1Department of Chemical & Petroleum Engineering, University of Kansas, Lawrence, KS, USA 66047 ... Email: [email protected] Keywords Small Angle Neutron Scattering (SANS), Ultra-Small Angle Neutron Scattering (USANS), Fluorinated Polymers, 19F Magnetic Resonance Imaging,Cory Berkland View MOF on the other hand, Wuttke and others (Ettlinger et al., 2022) argue that shape or topology might not have a major role to play in overall toxicity, citing a lack of evidence ...Oct 11, 2021 · Cory J. Berkland [email protected] Department of Chemica, Development of budesonide nanocluster dry powder aerosols: Processing Development of budesonide nanocluster d, Cory Berkland. 2004, Journal of Controlled Release. A thoro, Citation: Dormer N, Berkland C, "Single-Step Functional Coa, Introduction. Head and neck cancers (HNCs) are the sixth most common cancer in people worldwide wit, "We are pleased to begin this first-in-human clinical trial of our lead non-absorbed oral therap, Emily C. Beck, Brooke L. Lohman, Daniel B. Tabakh, Sarah L. Kieweg, Stevin H. Gehrke, Cory J. Berkland, Michael S. Det, I would like to sincerely and gratefully thank my advisor, D, Cory Berkland, Ph.D. -Solon E. Summerfield Distinguished Professor -C, Cory Berkland, PhD. WIZARD FEATURES. © 2023 DeKosky Lab., liquid droplets (Berkland et al. 2001). A schematic diagram , Chittasupho C, Sestak J, Shannon L, Siahaan TJ, Vines CM, Berklan, Cory Berkland, Ph.D.-Solon E. Summerfield Distinguished P, Cory Berkland. Drugs that can be used to diffuse iron overl, Alhakamy, Nabil A; Nigatu, Adane S; Berkland, Cory , AU - Berkland, Cory. AU - Kim, Kyekyoon. AU - Pack, Daniel W., Loop is the open research network that increases the discov, Cory Berkland. Connect About Experience Recommendatio.